NO883750D0 - PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PIPERIDE INGREDIENTS. - Google Patents

PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PIPERIDE INGREDIENTS.

Info

Publication number
NO883750D0
NO883750D0 NO883750A NO883750A NO883750D0 NO 883750 D0 NO883750 D0 NO 883750D0 NO 883750 A NO883750 A NO 883750A NO 883750 A NO883750 A NO 883750A NO 883750 D0 NO883750 D0 NO 883750D0
Authority
NO
Norway
Prior art keywords
procedure
preparation
therapeutic active
piperide
ingredients
Prior art date
Application number
NO883750A
Other languages
Norwegian (no)
Other versions
NO883750L (en
Inventor
Hitoshi Oinuma
Motosuke Yamanaka
Kazutoshi Miyake
Tomonori Hoshiko
Norio Minami
Tadao Shoji
Yoshiharu Daiku
Kohei Sawada
Kenichi Nomoto
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP62209728A external-priority patent/JP2584454B2/en
Priority claimed from JP20972787A external-priority patent/JPH0819083B2/en
Priority claimed from JP20972687A external-priority patent/JP2637989B2/en
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NO883750D0 publication Critical patent/NO883750D0/en
Publication of NO883750L publication Critical patent/NO883750L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/54—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO88883750A 1987-08-24 1988-08-22 PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PIPERIDE INGREDIENTS. NO883750L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP62209728A JP2584454B2 (en) 1987-08-24 1987-08-24 Piperidine derivative and arrhythmia therapeutic / prophylactic agent containing the same
JP20972787A JPH0819083B2 (en) 1987-08-24 1987-08-24 Sulfonamide derivative and arrhythmia treatment / prevention agent containing the same
JP20972687A JP2637989B2 (en) 1987-08-24 1987-08-24 Piperidine derivative and arrhythmia therapeutic / prophylactic agent containing the same

Publications (2)

Publication Number Publication Date
NO883750D0 true NO883750D0 (en) 1988-08-22
NO883750L NO883750L (en) 1989-02-27

Family

ID=27329045

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88883750A NO883750L (en) 1987-08-24 1988-08-22 PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PIPERIDE INGREDIENTS.

Country Status (11)

Country Link
US (2) US4977165A (en)
EP (1) EP0304888B1 (en)
KR (1) KR910002581B1 (en)
CA (1) CA1263658A (en)
DE (1) DE3875866T2 (en)
DK (1) DK470488A (en)
ES (1) ES2045044T3 (en)
GR (1) GR3006380T3 (en)
HU (1) HU207043B (en)
NO (1) NO883750L (en)
PH (1) PH25458A (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906634A (en) * 1988-03-08 1990-03-06 Schering A.G. Novel N-[4-(aminosubstituted)phenyl]methanesulfonamides and their use as cardiovascular agents
JP3065659B2 (en) * 1989-07-25 2000-07-17 ファルマシア・アンド・アップジョン・カンパニー Antiarrhythmic tertiary amine-alkenyl-phenyl-alkanesulfonamide
US5405997A (en) * 1989-07-25 1995-04-11 The Upjohn Company Antiarrhythmic methanesulfonamides
EP0532629B1 (en) * 1990-06-07 1996-11-06 Merrell Pharmaceuticals Inc. 1-piperidinyl alkanoylarylsulfonamide derivatives
US5478846A (en) * 1990-06-07 1995-12-26 Merrell Dow Pharmaceuticals Inc. 1-piperidinyl alkanoylanyl sulfonamides for treatment of cardiac arrhythmia
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof
US5254689A (en) * 1992-02-25 1993-10-19 American Home Products Corporation Piperdinyl and piperazinyl derivatives
US5202346A (en) * 1992-02-25 1993-04-13 American Home Products Corporation Piperidinyl and piperazinyl derivatives
CA2318215A1 (en) * 1998-02-02 1999-08-05 Merck & Co., Inc. Platelet aggregation inhibition using low molecular weight heparin in combination with a gp iib/iiia antagonist
US6136794A (en) * 1998-02-02 2000-10-24 Merck & Co., Inc. Platelet aggregation inhibition using low molecular weight heparin in combination with a GP IIb/IIIa antagonist
GB9901147D0 (en) * 1999-01-19 1999-03-10 Merck Sharp & Dohme Therapeutic agents
DE10000739A1 (en) * 2000-01-11 2001-07-12 Merck Patent Gmbh New piperidine and piperazine derivatives which are antagonists of certain serotonin receptors, are useful in treatment of, e.g. eating disorders, stroke, anxiety or Parkinson's disease
EP1467986A1 (en) 2002-01-17 2004-10-20 Eli Lilly And Company Aza-cyclic compounds as modulators of acetylcholine receptors
GB0326221D0 (en) 2003-11-10 2003-12-17 Merck Sharp & Dohme Therapeutic agents,compositions,preparations and uses
GB0419192D0 (en) * 2004-08-27 2004-09-29 Merck Sharp & Dohme Therapeutic agents
GB0426313D0 (en) * 2004-12-01 2005-01-05 Merck Sharp & Dohme Therapeutic agents
WO2011058766A1 (en) * 2009-11-16 2011-05-19 Raqualia Pharma Inc. Aryl carboxamide derivatives as ttx-s blockers
WO2015040352A1 (en) * 2013-09-18 2015-03-26 Redx Pharma Limited Agricultural chemicals

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB993584A (en) * 1962-01-24
US3968242A (en) * 1974-08-26 1976-07-06 Mead Johnson & Company Sulfonamidoaminopropiophenone interceptive process
US4044150A (en) * 1976-06-18 1977-08-23 Mead Johnson & Company Antihypertensive 4'-[1-hydroxy-2-[(1-phenoxy ethyl)-amino]ethyl]methanesulfonanilide and salts thereof and therapeutic use
DE3306697A1 (en) * 1983-02-25 1984-08-30 Bayer Ag, 5090 Leverkusen SUBSTITUTED MALEINIC ACID IMIDES
US4544654A (en) * 1984-03-20 1985-10-01 Schering A.G. Substituted sulfonamidobenzamides, antiarrhythmic agents and compositions thereof
PH23283A (en) * 1986-02-26 1989-06-30 Eisai Co Ltd Piperidine derivative, pharmaceutical composition containing the same and method of use thereof

Also Published As

Publication number Publication date
DE3875866D1 (en) 1992-12-17
KR890003691A (en) 1989-04-17
ES2045044T3 (en) 1994-01-16
EP0304888B1 (en) 1992-11-11
NO883750L (en) 1989-02-27
HU207043B (en) 1993-03-01
GR3006380T3 (en) 1993-06-21
KR910002581B1 (en) 1991-04-27
HUT48587A (en) 1989-06-28
EP0304888A1 (en) 1989-03-01
DK470488D0 (en) 1988-08-23
DK470488A (en) 1989-02-25
US5082850A (en) 1992-01-21
CA1263658A (en) 1989-12-05
PH25458A (en) 1991-07-01
US4977165A (en) 1990-12-11
DE3875866T2 (en) 1993-04-15

Similar Documents

Publication Publication Date Title
NO884154D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PREPARATIONS.
NO883974D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TETRAHYDRO-HYDROXYPYRANON DERIVATIVES.
NO871277D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE OXADIAZOLES.
NO871266D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CHINAZOLINE DERIVATIVES.
NO871267D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TIAZEPINE COMPOUNDS.
NO875082D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TETRAHYDROPYRIDINE OXIMS.
NO874869D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE RELATIONS.
NO870526L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE DICHLORANILIN DERIVATIVES.
NO884473D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE IMIDAZOLS.
NO874032L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CATECHOLD DERIVATIVES.
NO883750L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PIPERIDE INGREDIENTS.
NO862373D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TIENOPYRIDONES.
NO883485L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PIPERIDINYL-ISOKINOLINE COMPOUNDS.
NO875488D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ALKANSULPHONANILIDE DERIVATIVES.
NO910874L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PIPERIDE INGREDIENTS.
NO890155L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE INDOLPIPERIDIN COMPOUNDS.
NO880667D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ARYLPIPERAZINYL-ALKYLENE-PHENYL-HETEROCYCLIC COMPOUNDS.
NO873680L (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE SULPHONAMIDO-ETHYL COMPOUNDS.
NO168247C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5-METOXY-ALKYL-AMMONIUM-TETRAHYDROFURANES.
NO882281D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRAZINAMIDES.
NO871907D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ALKENAMIDE DERIVATIVES.
NO892871D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE RELATIONS.
NO882282L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRAZINAMIDES.
NO883959L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PHENOLESTERS.
NO853525L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE QUINOLIZINON DERIVATIVES.